undamentalytics Newsletter

Afya Ltd valuation and forecast

Explore the models for Afya Ltd, adjust their assumptions and compare your own valuation with the platform's.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: every model's value for Afya Ltd is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.

Price vs value

Under review: share count (4m) is 0.044x the market-data count (88m). We'll show the comparison once resolved.

Analyst recommendations

8 analysts, Nov 2026
Buy450%
Hold338%
Sell113%

Monthly trend

  1. Nov 202622318
  2. Oct 20261528
  3. Sep 20261539

Counts of recommendations published by analysts covering Afya Ltd, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Price history

Loading chart…

Third-party market data · may be delayed

The assumptions

Free cash flow (TTM, FY2025 Q4)
$174M
Less stock-based pay
$2.7M
Cash flow we value
$188M
Growth, years 1–5 (base)
%
Then fading to
2.5%
Discount rate
8.5%
Net cash added
-$177M
Diluted shares
4M

What would move the value

Growth 5 points lower
−26%
Growth 5 points higher
+33%
Free-cash-flow margin 1 point lower
−3%
Discount rate 1 point higher
−15%

Change in our model value when one input moves, all else equal.

AFYA valuation questions

How does Fundamentalytics value Afya Ltd?
We use the models that fit Afya Ltd's business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.

Data: SEC EDGAR filings, retrieved November 2, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Afya Ltd.

Compare with peers